Rtw Investments »

Medline shares owned by Rtw Investments

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 70k 42.00

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Medline

Carlyle
H&F Corporate Investors X
Vanguard Group
Capital Research Global Investors
BlackRock
Baillie Gifford & Co
Massachusetts Financial Services
WCM Investment Management
T. Rowe Price Investment Management
Viking Global Investors
Durable Capital Partners
Norges Bank Investment Management
Artisan Partners Limited Partnership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors

View all funds holding Medline